Receptos appoints Mary Szela and Richard Heyman to board of directors

Biopharmaceutical company Receptos (Nasdaq: RCPT) has appointed Mary Szela and Richard Heyman to the board of directors. They will both serve as Class II directors with terms of office expiring, and to be renewed, at the 2015 annual meeting of stockholders. They will also serve as members of the board’s nominating and corporate governance committee.

Bill Rastetter, chairman of the board of directors at Receptos, said: “"We are pleased to welcome both Mary and Rich to the Receptos board of directors. Mary's extensive marketing and commercial expertise brings a new and valuable skillset to our board as Receptos matures, while Rich's proven track record and deep background in drug discovery and development will provide valuable insight, experience and leadership. We look forward to working with both of them."